Press release
Theranostics Market to Reach USD 12.5 Billion by 2034
Theranostics
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/49320
Driven by advances in molecular imaging, radiolabeled drugs, and companion diagnostics, theranostics is transforming cancer treatment, particularly in oncology and nuclear medicine.
Key Takeaways
• Market Size: USD 5.3 billion (2024) → USD 12.5 billion (2034)
• CAGR: 9.1 % (2025-2034)
• Dominant Segment: Oncology applications account for over 70 % of market revenue
• Emerging Focus: Neurodegenerative and cardiovascular diseases
• Leading Regions: North America dominates; Asia-Pacific expected to exhibit fastest growth
Market Story
Theranostics - the convergence of diagnostics and therapeutics - is revolutionizing how clinicians detect, monitor, and treat diseases.
By linking diagnostic imaging with targeted therapy, theranostic agents enable real-time tracking of treatment efficacy, reducing trial-and-error medicine.
The growing success of radiotheranostic drugs such as Lutathera® (lutetium Lu 177 dotatate) and Pluvicto® (lutetium Lu 177 vipivotide tetraxetan) in cancer care has accelerated global adoption.
These agents target specific tumor biomarkers, delivering radiation directly to cancer cells while minimizing harm to healthy tissue.
Beyond oncology, research in neurotheranostics (for Alzheimer's and Parkinson's) and cardiovascular molecular imaging is opening new frontiers for early diagnosis and personalized intervention.
Segmentation Overview
By Product Type
• Radiopharmaceuticals
• Companion Diagnostics
• Imaging Agents
• Therapeutic Agents
By Application
• Oncology (Prostate, Neuroendocrine, Breast, Lung, Thyroid)
• Neurology
• Cardiovascular Disorders
• Autoimmune & Inflammatory Diseases
• Others
By End User
• Hospitals
• Diagnostic Imaging Centers
• Research & Academic Institutes
• Pharmaceutical & Biotech Companies
By Region
• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East & Africa
Explore Full Report here: https://exactitudeconsultancy.com/reports/49320/theranostics-market
Recent Developments
• Novartis AG expanded production of its FDA-approved radioligand therapies Pluvicto® and Lutathera® to meet surging oncology demand.
• GE HealthCare launched a new PET/CT imaging platform optimized for theranostic workflow integration.
• Telix Pharmaceuticals Ltd. received regulatory approval for Illuccix® (68Ga-PSMA-11), a prostate cancer diagnostic radiopharmaceutical.
• Bayer AG announced the development of targeted alpha therapies (TATs) using actinium-based isotopes for advanced solid tumors.
• Siemens Healthineers introduced AI-driven molecular imaging software that improves diagnostic precision in radiotheranostics.
Expert Quote
"Theranostics represents the future of medicine - where diagnosis and therapy converge for unmatched treatment accuracy.
Its role in oncology and beyond underscores the transition from generalized care to precision-guided healthcare,"
said Irfan Tamboli, Business Development Executive at Exactitude Consultancy.
Get Your Exclusive Offer with up to 10% Discount : https://exactitudeconsultancy.com/checkout/?currency=USD&type=single_user_license&report_id=49320
Market Drivers
• Increasing incidence of cancer and chronic diseases
• Growing adoption of radiopharmaceuticals and molecular imaging
• Advancements in AI-driven image analysis and companion diagnostics
• Rising government and private investment in personalized medicine R&D
• Expansion of PET and SPECT imaging infrastructure globally
Forecast and Outlook
The next decade will mark an era of precision oncology dominance, with theranostics enabling early diagnosis, real-time monitoring, and personalized dose delivery.
Integration of AI, big data analytics, and biomarker discovery will further enhance patient outcomes and accelerate drug development timelines.
The future of theranostics will expand beyond oncology into neurology, cardiology, and immunology, transforming chronic disease management through patient-specific targeting.
Emerging economies will play a crucial role as radiopharmacy networks and nuclear medicine centers expand globally.
Regional Insights
• North America: Largest market; strong nuclear medicine ecosystem and advanced healthcare infrastructure.
• Europe: Significant growth supported by EU investments in radiopharmaceutical production and clinical research.
• Asia-Pacific: Fastest-growing region; rising healthcare investment in precision imaging and molecular diagnostics.
• Latin America: Expanding diagnostic imaging network and partnerships in oncology care.
• Middle East & Africa: Gradual adoption driven by public-private healthcare modernization efforts.
Conclusion
The Global Theranostics Market stands at the intersection of diagnostics, therapeutics, and data science, redefining precision medicine.
As healthcare moves toward personalized, value-based care, theranostics will play a pivotal role in optimizing treatment efficacy, patient safety, and healthcare economics.
Companies that innovate in radioligand development, AI-based imaging, and companion diagnostics will lead the next decade of growth.
This report is also available in the following languages : Japanese (セラノスティクス市場), Korean (테라노스틱스 시장), Chinese (治疗诊断市场), French (Marché de la théranostique), German (Theranostik-Markt), and Italian (Mercato della Teranostica), etc.
Request for a sample of this research report at (Use Corporate Mail ID for Quick Response) @ https://exactitudeconsultancy.com/reports/49320/theranostics-market#request-a-sample
Related Reports
Acute Radiation Syndrome Market
https://exactitudeconsultancy.com/reports/76062/acute-radiation-syndrome-market
US Addictions Therapeutics Market
https://exactitudeconsultancy.com/reports/76072/us-addictions-therapeutics-market
Pulmonary Surfactant Market
https://exactitudeconsultancy.com/reports/76083/pulmonary-surfactant-market
Alzheimer's Disease Treatment Market
https://exactitudeconsultancy.com/reports/76109/alzheimer-s-disease-treatment-market
About Us
Exactitude Consultancy is a market research & consulting services firm which helps its client to address their most pressing strategic and business challenges. Our market research helps clients to address critical business challenges and also helps make optimized business decisions with our fact-based research insights, market intelligence, and accurate data.
https://bulletin.exactitudeconsultancy.com/
https://www.thehealthanalytics.com/
https://www.analytica.global/
https://www.marketintelligencedata.com/
https://www.marketinsightsreports.com/
https://exactitudeconsultancy.com/
Connect Us:
Irfan Tamboli
PHONE NUMBER +1 (704) 266-3234
EMAIL ADDRESS: sales@exactitudeconsultancy.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Theranostics Market to Reach USD 12.5 Billion by 2034 here
News-ID: 4264262 • Views: …
More Releases from Exactitude Consultancy
Amnesia Market Growth: $3.5B in 2024 to $6.7B by 2034
The Amnesia market is set to expand at a CAGR of 6.8%, driven by growing prevalence of neurological disorders and advances in diagnostic and treatment options.
Introduction:
The Amnesia Market is projected to grow significantly, reaching a market value of $6.7 billion by 2034, up from $3.5 billion in 2024. This growth is driven by an increase in neurological disorders, advancements in cognitive treatments, and a growing demand for cognitive training devices,…
Pharma Contract Research Organization (CRO) Services Market Growth: $52B in 2024 …
The Pharma CRO Services market is expected to witness a robust CAGR of 6.1% from 2024 to 2034, driven by increased demand for outsourcing and rising drug development complexities.
Introduction:
The global Pharma Contract Research Organization (CRO) Services Market is projected to grow significantly, reaching $85 billion by 2034, up from $52 billion in 2024. This growth is primarily driven by the outsourcing trend within the pharmaceutical industry, the increasing complexity of…
Neuroendocrine Breast Tumor Market to Reach USD 4.5 Billion by 2034, Growing at …
Exactitude Consultancy's new report explores the growth of the Neuroendocrine Breast Tumor Market, driven by advancements in diagnostic methods, targeted therapies, and increasing research investments.
Introduction:
Exactitude Consultancy's latest market research report on the Neuroendocrine Breast Tumor Market forecasts strong growth from USD 2.3 billion in 2024 to USD 4.5 billion by 2034, growing at a CAGR of 7.5%. The market is driven by improvements in diagnostic technologies, increasing research into targeted…
Cutaneous Lupus Market to Reach USD 2.6 Billion by 2034, Growing at a CAGR of 8. …
Exactitude Consultancy's new report explores the increasing growth of the Cutaneous Lupus Market, driven by advancements in treatment options, diagnostic tools, and rising awareness.
Introduction:
Exactitude Consultancy's latest market research report on the Cutaneous Lupus Market forecasts significant growth from USD 1.2 billion in 2024 to USD 2.6 billion by 2034, growing at a CAGR of 8.1%. The market is driven by improvements in treatment strategies, increasing awareness of cutaneous lupus, and…
More Releases for Theranostics
Key Factor Supporting Global Theranostics Market Development in 2025: Rising Can …
Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
How Large Will the Theranostics Market Size By 2025?
The overall scale of the theranostics sector has experienced swift expansion lately, charting an increase from a valuation of $111.1 billion in 2024 to an anticipated $122.98 billion by 2025, reflecting a compound annual growth rate (CAGR) of 10.7%; this…
Theranostics Market in 2025 Detailed Study Analysis
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Theranostics Market -(Product (Diagnostic imaging, Radiopharmaceuticals, Biomarker screening and Software), Application (Prostate Cancer, Bone Metastasis, Other Cancers, Other Application), End-user (Hospitals & Cancer Care Centers, Theranostics Centers, and Research & Academic Centers)) Trends, Industry Competition Analysis, Revenue and Forecast To 2034."
According to the latest research by InsightAce Analytic, the Global Theranostics Market Size is valued…
Rising Cancer Prevalence Fuels Growth In The Theranostics Market Driver: Leading …
What combination of drivers is leading to accelerated growth in the theranostics market?
The theranostics market is forecasted to grow due to an upward trend in cancer cases. Cancer, a disease characterized by unchecked cell growth affecting numerous organs, is a leading cause of considerable illness and death globally. Theranostics, combining therapeutic and diagnostic aspects, holds significant prospects in managing cancer and chronic illnesses. This methodology paves the way for tailored…
Theranostics Market worth $4.3 billion by 2028
The report will help the market leaders/new entrants with information on the closest approximations of the revenue numbers for the overall theranostics market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and plan suitable go-to-market strategies.
Theranostics Market [https://www.marketsandmarkets.com/Market-Reports/theranostics-market-111696976.html?utm_source=abnewswire.com&utm_medium=referral&utm_campaign=paidpr] in terms of revenue was estimated to be worth $2.1 billion in 2023 and is poised to reach $4.3…
Theranostics Market: Pioneering Precision Medicine into 2030
The Theranostics Market was valued USD 1.9 Billion in 2023 and projected to reach USD 5.4 Billion by 2030, growing at a CAGR of 16.2% during the forecast period of 2024-2030.
The Theranostics Market report studies the competitive environment of the Theranostics Market based on company profiles and their efforts to increase product value and production. The Theranostics Market report discusses various factors driving or restraining the market, which will help…
Theranostics Market Is Booming Worldwide Just Published
Global Theranostics Market: An Overview
Theranostics is a new field of medicine which relies on targeted therapies to conduct specific targeted tests. These tests are mainly used for various forms of cancers. The key concern in the therapeutics involve patient centric care with the help of more personalised and precise approach. The technique relies on the use of diagnostic and therapeutic applications to form a single agent. The system is known…
